Probiotics to Promote Intestinal Health
Randomized Controlled Trial of Lactobacillus Rhamnosus GG to Promote Intestinal Health
Sponsor: Centers for Disease Control and Prevention
Listed as NCT02046512, this PHASE4 trial focuses on Anti-Infective Agents and Communicable Diseases and remains completed. Sponsored by Centers for Disease Control and Prevention, it has been updated 10 times since 2014, reflecting substantial change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
10 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
May 2022 — Jul 2024 [monthly]
Completed PHASE4
-
Jan 2021 — May 2022 [monthly]
Completed PHASE4
▶ Show 5 earlier versions
-
Feb 2019 — Jan 2021 [monthly]
Completed PHASE4
Status: Active Not Recruiting → Completed
-
Jun 2018 — Feb 2019 [monthly]
Active Not Recruiting PHASE4
-
May 2018 — Jun 2018 [monthly]
Active Not Recruiting PHASE4
Status: Unknown Status → Active Not Recruiting
-
Sep 2017 — May 2018 [monthly]
Unknown Status PHASE4
Status: Enrolling By Invitation → Unknown Status
-
Jan 2017 — Sep 2017 [monthly]
Enrolling By Invitation PHASE4
First recorded
Jan 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Centers for Disease Control and Prevention
- Washington University School of Medicine
For direct contact, visit the study record on ClinicalTrials.gov .